sábado, 29 de noviembre de 2014

Genomics|Features|Pharmacogenomics

Genomics|Features|Pharmacogenomics



Pharmacogenomics



Pharmacogenomic Testing in Practice: How Much Evidence Do We Need? - November 26, 2014



test tubes being filled
Evidence required to demonstrate clinical utility of pharmacogenetic testing: The debate continues.External Web Site Icon 
N K Gillis and F Innocenti. Clinical Pharmacology & Therapeutics (2014); 96 6, 655–657.
Useless until proven effective: The clinical utility of preemptive pharmacogenetic testing.External Web Site Icon 
A C J W Janssens and P A Deverka  Clinical Pharmacology & Therapeutics (2014); 96 6, 652–654.
Meaningful use of pharmacogenetics.External Web Site Icon 
M J Ratain and J A Johnson Clinical Pharmacology & Therapeutics (2014); 96 6, 650–652. 

Evidence-based Pharmacogenomic Testing: Where are we? - October 16, 2014



DNA inside a capsule
Editorial: A call for accurate pharmacogenetic labeling: Telling it like it is.External Web Site Icon 
Wylie Burke, et al. JAMA Internal Medicine, October 13, 2014 
CDC paper:  Prioritizing genomic applications for action by level of evidence: a horizon-scanning methodExternal Web Site Icon.
Dotson W et al, Clin Pharmacol Ther. 2014 Apr;95(4):394-402.

Pharmacogenomics: Gap Between Research & Practice - September 4, 2014



a hand holding DNA
Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties.External Web Site Icon 
Dickinson Barry, et al.  Pharmacogenomics and personalized medicine, July 2014
Implementation of personalized medicine services in community pharmacies: need for more education.External Web Site Icon  Alexander KM, et al. J Am Pharm Assoc (2003). 2014 Aug 22:e326-e333.
CDC paper:  Prioritizing genomic applications for action by level of evidence: a horizon-scanning methodExternal Web Site Icon. Dotson W et al, Clin Pharmacol Ther. 2014 Apr;95(4):394-402.

No hay comentarios:

Publicar un comentario